Rezolute (RZLT) Enterprise Value (2010 - 2026)
Rezolute's (RZLT) quarterly Enterprise Value came in at -$120.2 million in Q1 2026, down 38.36% year-on-year from -$195.1 million in Q1 2025, and up 9.53% quarter-over-quarter from -$132.9 million in Q4 2025.
Rezolute (RZLT) Enterprise Value (2010 - 2026) Analysis & Trends
Rezolute has disclosed Enterprise Value across 12 years of filings, most recently posting -$120.2 million for Q1 2026.
- Enterprise Value for Q1 2026 came in at -$120.2 million, down 38.36% year-over-year; the trailing twelve-month figure through Mar 2026 was -$120.2 million (down 38.36% YoY), and the FY2025 annual result was -$167.9 million, down 32.3% from the prior year.
- Enterprise Value came in at -$120.2 million for Q1 2026 at Rezolute, up from -$132.9 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$63.4 million in Q1 2022 to a low of -$167.9 million in Q2 2025.
- The 5-year median for Enterprise Value is -$108.3 million (2024), against an average of -$116.6 million.
- Across the five-year window, Enterprise Value sank 313.73% in 2022 and jumped 36.9% in 2023, its largest moves.
- Rezolute's Enterprise Value stood at -$146.7 million in 2022, then surged by 36.9% to -$92.6 million in 2023, then decreased by 4.21% to -$96.5 million in 2024, then plunged by 37.71% to -$132.9 million in 2025, then increased by 9.53% to -$120.2 million in 2026.
- The last three Enterprise Value figures came in at -$120.2 million (Q1 2026), -$132.9 million (Q4 2025), and -$152.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | Rezolute | 520.13 Mn | 520.13 Mn | - | -120.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -120.23 Mn |
| Dec 31, 2025 | -132.89 Mn |
| Sep 30, 2025 | -152.20 Mn |
| Jun 30, 2025 | -167.86 Mn |
| Mar 31, 2025 | -86.90 Mn |
| Dec 31, 2024 | -96.50 Mn |
| Sep 30, 2024 | -108.27 Mn |
| Jun 30, 2024 | -126.87 Mn |
| Mar 31, 2024 | -79.99 Mn |
| Dec 31, 2023 | -92.60 Mn |
| Sep 30, 2023 | -98.80 Mn |
| Jun 30, 2023 | -101.90 Mn |
| Mar 31, 2023 | -103.06 Mn |
| Dec 31, 2022 | -146.75 Mn |
| Sep 30, 2022 | -154.32 Mn |
| Jun 30, 2022 | -150.41 Mn |
| Mar 31, 2022 | -63.42 Mn |
| Dec 31, 2021 | -77.40 Mn |
| Sep 30, 2021 | -37.30 Mn |
| Jun 30, 2021 | -41.05 Mn |